Evonik Industries (FRA:EVK) has been assigned a €38.70 ($46.07) price objective by investment analysts at Warburg Research in a report released on Wednesday. The brokerage currently has a “buy” rating on the stock. Warburg Research’s price target points to a potential upside of 23.76% from the company’s previous close.
Other analysts also recently issued research reports about the stock. Commerzbank set a €33.00 ($39.29) price objective on shares of Evonik Industries and gave the stock a “buy” rating in a research note on Monday, September 18th. Berenberg Bank set a €33.00 ($39.29) price objective on shares of Evonik Industries and gave the stock a “buy” rating in a research note on Friday, September 15th. Credit Suisse Group set a €34.30 ($40.83) price target on shares of Evonik Industries and gave the company a “buy” rating in a research note on Tuesday, September 26th. Baader Bank set a €41.00 ($48.81) price target on shares of Evonik Industries and gave the company a “buy” rating in a research note on Thursday, September 21st. Finally, Barclays set a €34.50 ($41.07) price target on shares of Evonik Industries and gave the company a “buy” rating in a research note on Friday, September 29th. Two investment analysts have rated the stock with a sell rating, six have issued a hold rating and eleven have given a buy rating to the company. The stock currently has a consensus rating of “Hold” and a consensus target price of €33.81 ($40.24).
Shares of Evonik Industries (FRA EVK) opened at €31.27 ($37.23) on Wednesday. The stock has a market cap of $14,890.00 and a PE ratio of 19.92. Evonik Industries has a 12 month low of €26.78 ($31.88) and a 12 month high of €32.97 ($39.25).
ILLEGAL ACTIVITY NOTICE: This article was originally published by Markets Daily and is the property of of Markets Daily. If you are reading this article on another site, it was illegally stolen and republished in violation of U.S. and international trademark & copyright law. The legal version of this article can be viewed at https://www.themarketsdaily.com/2018/01/10/evonik-industries-evk-pt-set-at-38-70-by-warburg-research.html.
Evonik Industries AG engages in the specialty chemicals business worldwide. It operates through Nutrition & Care, Resource Efficiency, Performance Materials, and Services segments. The Nutrition & Care segment offers specialty chemicals, including amphoteric surfactants, ceramides, phytosphingosines, oleochemical quaternary derivatives, organically modified silicones, superabsorbents, amino acids and amino acid derivatives, synthesis products, pharmaceutical polymers, and DL-methionine for use in consumer goods, animal nutrition, and healthcare sectors.
Receive News & Ratings for Evonik Industries Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evonik Industries and related companies with MarketBeat.com's FREE daily email newsletter.